Brian Pepin is CEO and founder of Rune Labs, a software and data platform for neuromodulation and brain therapies of the future.
Brian has been at the intersection of engineering and neuroscience for more than a decade, starting with his graduate work at Berkeley on novel brain-machine interfaces. He was driven to found Rune Labs after recognizing the opportunity to build the quality brain data foundation needed to support the engineering of new therapies and medical devices for degenerative brain diseases like Parkinson’s and other neurological disorders, a long-standing frustration in the field.
Before starting Rune Labs in 2018, Brian spent nearly five years at the Alphabet/Google company Verily Life Sciences, leading teams that built data-driven healthcare products and partnerships
Brian also spent nearly five years at Verily Life Sciences
While at Verily, he helped launch Galvani Bioelectronics, a $1 billion joint venture with GlaxoSmithKline to develop new therapies for immune disease based on stimulation of peripheral nerves, running the Verily team of engineers at the JV for two years.
Brian holds an MSEE in electrical engineering from UC Berkeley and a BSEE from the University of Washington.